» Articles » PMID: 16263982

Association of Insulin-like Growth Factor I and Insulin-like Growth Factor-binding Protein-3 with Intelligence Quotient Among 8- to 9-year-old Children in the Avon Longitudinal Study of Parents and Children

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2005 Nov 3
PMID 16263982
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insulin-like growth factor I (IGF-I) is a hormone that mediates the effects of growth hormone and plays a critical role in somatic growth regulation and organ development. It is hypothesized that it also plays a key role in human brain development. Previous studies have investigated the association of low IGF-I levels attributable to growth hormone receptor deficiency with intelligence but produced mixed results. We are aware of no studies that investigated the association of IGF-I levels with IQ in population samples of normal children.

Objectives: To investigate the association of circulating levels of IGF-I and its principle binding protein, IGF-binding protein-3 (IGFBP-3), in childhood with subsequent measures of IQ.

Methods: The cohort study was based on data for 547 white singleton boys and girls, members of the Avon Longitudinal Study of Parents and Children, with IGF-I and IGFBP-3 measurements (obtained at a mean age of 8.0 years) and IQ measured with the Wechsler Intelligence Scale for Children (at a mean age of 8.7 years). We also investigated associations with measures of speech and language based on the Wechsler Objective Reading Dimensions test (measured at an age of 7.5 years) and the Wechsler Objective Language Dimensions test (listening comprehension subtest only, measured at an age of 8.7 years). For some children (n = 407), IGF-I (but not IGFBP-3) levels had been measured at approximately 5 years of age in a previous study. Linear regression models were used to investigate associations of the IGF-I system with the measures of cognitive function.

Results: Three hundred one boys and 246 girls were included in the sample. IGF-I levels (mean +/- SD) were 142.6 +/- 53.9 ng/mL for boys and 154.4 +/- 51.6 ng/mL for girls. IQ scores (mean +/- SD) were 106.05 +/- 16.6 and 105.27 +/- 15.6 for boys and girls, respectively. IGF-I levels were associated positively with intelligence. For every 100 ng/mL increase in IGF-I, IQ increased by 3.18 points (95% confidence interval [CI]: 0.52 to 5.84 points). These positive associations were seen in relation to the verbal component (coefficient: 4.27; 95% CI: 1.62 to 6.92), rather than the performance component (coefficient: 1.06; 95% CI: -1.67 to 3.78), of IQ. There was no evidence that associations with overall IQ differed between boys and girls. In a data set with complete information on confounders (n = 484), controlling for birth weight (adjusted for gestation), breastfeeding, and BMI slightly strengthened the associations of IGF-I levels with IQ. Additionally controlling for maternal education and IGFBP-3 levels attenuated the associations (change in IQ for every 100 ng/mL increase in IGF-I levels: 2.51 points; 95% CI: -0.42 to 5.44 points). The weakening of associations in models controlling for markers of parental socioeconomic position and education could reflect shared influences of parental IGF levels on parents' own educational attainment and their offspring's IGF-I levels. In unadjusted models examining associations of Wechsler Objective Reading Dimensions and Wechsler Objective Language Dimensions test scores with IGF-I levels, there was no strong evidence that performance on either of these tests was associated with circulating IGF-I levels, although positive associations were seen with both measures. Associations between IGF-I levels measured at age 5 and Wechsler Intelligence Scale for Children scores (n = 407) were similar to those for IGF-I levels measured at age 7 to 8. For every 100 ng/mL increase in IGF-I levels at 5 years of age, IQ increased by 2.3 points (95% CI: -0.21 to 4.89 points).

Conclusions: This study provides some preliminary evidence that IGF-I is associated with brain development in childhood. Additional longitudinal research is required to clarify the role of IGF-I in neurodevelopment. Because IGF-I levels are modifiable through diet and other environmental exposures, this may be one pathway through which the childhood environment may influence neurodevelopment.

Citing Articles

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Li Y, Liu R, Zhao Z Pharmaceutics. 2025; 17(1).

PMID: 39861756 PMC: 11769103. DOI: 10.3390/pharmaceutics17010109.


Anthropometric and sociodemographic variables, but not preconception or prenatal maternal nutrition supplementation, predict neurodevelopment in offspring of the 'Women First' trial.

Waldrop S, Chowdhury D, Westcott J, Biasini F, Garces A, Figueroa L Matern Child Nutr. 2024; 20(4):e13703.

PMID: 39044360 PMC: 11574664. DOI: 10.1111/mcn.13703.


Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment.

Shnayder N, Ashkhotov A, Trefilova V, Nurgaliev Z, Novitsky M, Petrova M Int J Mol Sci. 2023; 24(9).

PMID: 37175399 PMC: 10178334. DOI: 10.3390/ijms24097692.


Tendencies Toward Supernormality/Subnormality in Generating Attractive and Unattractive Female and Male Avatars: Gender Differences.

Markovic S, Bulut T Arch Sex Behav. 2023; 52(6):2317-2336.

PMID: 36995537 DOI: 10.1007/s10508-023-02575-w.


International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood.

Hokken-Koelega A, van der Steen M, Boguszewski M, Cianfarani S, Dahlgren J, Horikawa R Endocr Rev. 2023; 44(3):539-565.

PMID: 36635911 PMC: 10166266. DOI: 10.1210/endrev/bnad002.